DNMT1 and ovarian carcinoma: In ovarian cancer cell line CP70, DNMT1 siRNA treatment led to a partial removal of DNA methylation from three inactive promoter CpG islands, TWIST, RASSF1A, and HIN-1, and restored the expression of these genes [8].